Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Healthcare Distributors Industry Analysis

UpdatedNov 15, 2025
DataAggregated Company Financials
Companies1
  • 7D0.1%
  • 3M3.2%
  • 1Y13.9%
  • YTDn/a

The Healthcare Distributors industry has stayed flat over the last week. As for the the longer term, the industry is up 16% over the past 12 months. Looking forward, earnings are forecast to grow by 5.3% annually.

Industry Valuation and Performance

Has the Swiss Healthcare Distributors Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 17 Nov 2025CHF 4.3bCHF 4.0bCHF 192.4m22.5x22.5x1.1x
Wed, 15 Oct 2025CHF 4.4bCHF 4.0bCHF 192.4m23.1x23.1x1.1x
Fri, 12 Sep 2025CHF 4.3bCHF 4.0bCHF 192.4m22.5x22.5x1.1x
Sun, 10 Aug 2025CHF 4.2bCHF 4.0bCHF 192.4m21.8x21.8x1x
Tue, 08 Jul 2025CHF 4.4bCHF 3.9bCHF 183.0m24.2x24.2x1.1x
Thu, 05 Jun 2025CHF 4.3bCHF 3.9bCHF 183.0m23.4x23.4x1.1x
Sat, 03 May 2025CHF 4.3bCHF 3.9bCHF 183.0m23.6x23.6x1.1x
Mon, 31 Mar 2025CHF 4.0bCHF 3.9bCHF 183.0m21.8x21.8x1x
Wed, 26 Feb 2025CHF 4.1bCHF 3.8bCHF 169.7m24.1x24.1x1.1x
Fri, 24 Jan 2025CHF 4.0bCHF 3.8bCHF 169.7m23.4x23.4x1x
Sun, 22 Dec 2024CHF 3.6bCHF 3.8bCHF 169.7m21.4x21.4x1x
Tue, 19 Nov 2024CHF 3.8bCHF 3.8bCHF 169.7m22.4x22.4x1x
Thu, 17 Oct 2024CHF 3.7bCHF 3.8bCHF 169.7m22.1x22.1x1x
Sat, 14 Sep 2024CHF 3.7bCHF 3.8bCHF 169.7m21.8x21.8x1x
Mon, 12 Aug 2024CHF 3.6bCHF 3.8bCHF 169.7m21.2x21.2x0.9x
Wed, 10 Jul 2024CHF 3.7bCHF 3.8bCHF 164.9m22.6x22.6x1x
Fri, 07 Jun 2024CHF 3.7bCHF 3.8bCHF 164.9m22.6x22.6x1x
Sun, 05 May 2024CHF 3.5bCHF 3.8bCHF 164.9m21.3x21.3x0.9x
Tue, 02 Apr 2024CHF 3.7bCHF 3.8bCHF 164.9m22.7x22.7x1x
Thu, 29 Feb 2024CHF 3.8bCHF 4.1bCHF 160.5m23.5x23.5x0.9x
Sat, 27 Jan 2024CHF 3.8bCHF 4.1bCHF 160.5m23.4x23.4x0.9x
Mon, 25 Dec 2023CHF 3.6bCHF 4.1bCHF 160.5m22.5x22.5x0.9x
Wed, 22 Nov 2023CHF 3.5bCHF 4.1bCHF 160.5m21.9x21.9x0.9x
Fri, 20 Oct 2023CHF 3.3bCHF 4.1bCHF 160.5m20.3x20.3x0.8x
Sun, 17 Sep 2023CHF 3.5bCHF 4.1bCHF 160.5m21.8x21.8x0.8x
Tue, 15 Aug 2023CHF 3.4bCHF 4.1bCHF 160.5m21.1x21.1x0.8x
Thu, 13 Jul 2023CHF 3.5bCHF 4.0bCHF 165.1m21.3x21.3x0.9x
Sat, 10 Jun 2023CHF 3.6bCHF 4.0bCHF 165.1m21.6x21.6x0.9x
Mon, 08 May 2023CHF 3.9bCHF 4.0bCHF 165.1m23.4x23.4x1x
Wed, 05 Apr 2023CHF 3.9bCHF 4.0bCHF 165.1m23.5x23.5x1x
Fri, 03 Mar 2023CHF 3.6bCHF 3.9bCHF 171.3m21.3x21.3x0.9x
Sun, 29 Jan 2023CHF 3.6bCHF 3.9bCHF 171.3m21x21x0.9x
Tue, 27 Dec 2022CHF 3.7bCHF 3.9bCHF 171.3m21.9x21.9x0.9x
Thu, 24 Nov 2022CHF 3.5bCHF 3.9bCHF 171.3m20.7x20.7x0.9x
Price to Earnings Ratio

20.7x


Total Market Cap: CHF 3.5bTotal Earnings: CHF 171.3mTotal Revenue: CHF 3.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Healthcare Distributors Industry Price to Earnings3Y Average 22.3x202320242025
Current Industry PE
    There is only one company in the Swiss Healthcare Distributors industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Healthcare Distributors industry have grown 3.9% per year over the last three years, while revenues have remained mostly flat.
  • This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.

Industry Comparison

How does Swiss Healthcare Distributors compare with similar industries?

CH Market1.26%
Healthcare2.22%
Healthcare Services0.44%
Healthcare Distributors0.12%
Healthcare Services11.11%
Healthcare Facilities1.59%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GALE GalenicaCHF 86.900.1%
+CHF 5.0m		13.9%PE22.5x

Latest News

GALE
CHF 86.90
Galenica
7D
0.1%
1Y
13.9%

GALE: Digital Integration And New Pharmacy Model Will Shape Future Performance

Analysts have raised their price target for Galenica, increasing the fair value estimate from CHF 85.50 to CHF 86.17. This adjustment is attributed to improved revenue growth and modest enhancements in profit margin projections.